NIAGEN SUPPLY AGREEMENTNiagen Supply Agreement • May 8th, 2014 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
THIS NIAGEN SUPPLY AGREEMENT (the "Agreement"), is made and entered into as of January 3, 2014 (the “Effective Date”) by and between 5Linx Enterprises Inc, a Delaware Corporation with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 ("Buyer") and ChromaDex Inc. a California corporation with principal offices located at 10005 Muirlands, Blvd, Suite G, Irvine, CA 92618, USA (“Seller”).
ADDENDUM TO THE NIAGEN™ SUPPLY AGREEMENT BETWEEN 5LINX ENTERPRISES, INC. AND CHROMADEX, INC.Niagen Supply Agreement • August 26th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Addendum (the “Addendum”) dated June 26, 2014 (“Addendum Effective Date”), is attached to and forms part of the NIAGEN SUPPLY AGREEMENT (the “Agreement”) dated January 3, 2014 made by and between ChromaDex, Inc., a California corporation, having a principal place of business at 10005 Muirlands Blvd, Suite G, Irvine, CA 92618 (“Seller”) and 5Linx Enterprises, Inc., a Delaware Corporation with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”). To the extent that any of the terms or conditions contained in this Addendum may contradict or conflict with any of the terms or conditions of the Agreement, it is expressly understood and agreed that the terms of this Addendum shall take precedence and supersede the Agreement.
ADDENDUM TO THE NIAGEN(TM) SUPPLY AGREEMENT BETWEEN 5LINX ENTERPRISES, INC. AND CHROMADEX, INC.Niagen Supply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Addendum (the “Addendum”) dated June 26, 2014 (“Addendum Effective Date”), is attached to and forms part of the NIAGEN SUPPLY AGREEMENT (the “Agreement”) dated January 3, 2014 made by and between ChromaDex, Inc., a California corporation, having a principal place of business at 10005 Muirlands Blvd, Suite G, Irvine, CA 92618 (“Seller”) and 5Linx Enterprises, Inc., a Delaware Corporation with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”). To the extent that any of the terms or conditions contained in this Addendum may contradict or conflict with any of the terms or conditions of the Agreement, it is expressly understood and agreed that the terms of this Addendum shall take precedence and supersede the Agreement.
SECOND AMENDMENT TO NIAGEN® SUPPLY AGREEMENTNiagen® Supply Agreement • August 26th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
THIS SECOND AMENDMENT is effective and binding as of the last date of signing of this Second Amendment (the “Effective Date of the Second Amendment”), by and between 5Linx Enterprises, Inc., with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”) and ChromaDex, Inc., with principals offices located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 (“Seller”).
FIRST AMENDMENT TO NIAGEN® SUPPLY AGREEMENTNiagen® Supply Agreement • August 26th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
THIS AMENDMENT is entered into this 31st day of March 2015 (the “Effective Date” of the First Amendment), by and between 5Linx Enterprises, Inc., with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”) and ChromaDex, Inc., with principals offices located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 (“Seller”).
NIAGEN SUPPLY AGGREEMENTNiagen Supply Agreement • July 12th, 2013 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
THIS AGREEMENT (the "Agreement"), is made and entered into as of July 9, 2013 (the “Effective Date”) by and between Thorne Research, Inc., with offices at 25820 Highway 2 West, Sandpoint, Idaho 83864 ("Buyer") and ChromaDex, Inc., with offices at 10005 Muirlands, Blvd, Suite G, Irvine, California 92618, USA (“Seller”).
